May 22, 2018 / 11:14 AM / a month ago

BRIEF-OncoDNA Signs Screening Collaboration With Kura Oncology

May 22 (Reuters) - OncoDNA:

* ONCODNA ANNOUNCES SCREENING COLLABORATION WITH KURA ONCOLOGY

* ONCODNA SAYS CO TO SUPPORT PATIENT ENROLMENT FOR KURA ONCOLOGY’S PHASE II TRIAL OF TIPIFARNIB

* ONCODNA SAYS FINANCIAL TERMS OF AGREEMENT HAVE NOT BEEN DISCLOSED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below